Office of Drug Evaluation II (ODE II)
Our Mission - The Office of Drug Evaluation II is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for addiction, allergy, analgesia, anesthesia, diabetes, endocrine, metabolism, pulmonary, and rheumatological conditions.
Director: Curtis J. Rosebraugh, M.D., M.P.H.
Deputy Director: Christine Nguyen, M.D. (acting)
Associate Director for Regulatory Affairs: Vacant
Project Specialists: Velma Cunningham and Stanley Allen
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Drug Evaluation II
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2310
Fax: (301) 796-9717